Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
This study has been completed.
Sponsor:
Friends Research Institute, Inc.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Friends Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT01131520
First received: May 21, 2010
Last updated: September 16, 2015
Last verified: September 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.
| Condition | Intervention |
|---|---|
|
Drug Abuse HIV Risk Behavior |
Behavioral: Computerized brief intervention Behavioral: Counselor delivered brief intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | SBIRT in New Mexico |
Resource links provided by NLM:
Further study details as provided by Friends Research Institute, Inc.:
Primary Outcome Measures:
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ] [ Designated as safety issue: No ]
- Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC) [ Time Frame: 3 month post-baseline ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 3 months post-baseline ] [ Designated as safety issue: No ]
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ] [ Designated as safety issue: No ]
- Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC) [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
- Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and THC [ Time Frame: 12 month post-baseline ] [ Designated as safety issue: No ]
- Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
- Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 12 month post-baseline ] [ Designated as safety issue: No ]
| Enrollment: | 360 |
| Study Start Date: | June 2010 |
| Study Completion Date: | July 2015 |
| Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Computerized Brief Intervention
Computerized one-session brief intervention for drug use
|
Behavioral: Computerized brief intervention
This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.
|
|
Active Comparator: Counselor delivered brief intervention
This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing
|
Behavioral: Counselor delivered brief intervention
This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.
|
Detailed Description:
Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 18 years or older
- Moderate risk category on the ASSIST scores
Exclusion Criteria:
- planning to move out of New Mexico in the next year
- receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01131520
Please refer to this study by its ClinicalTrials.gov identifier: NCT01131520
Locations
| United States, Maryland | |
| Friends Research Institute | |
| Baltimore, Maryland, United States, 21201 | |
Sponsors and Collaborators
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
Investigators
| Principal Investigator: | Robert P Schwartz, M.D. | Friends Research Institute, Inc. |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Friends Research Institute, Inc. |
| ClinicalTrials.gov Identifier: | NCT01131520 History of Changes |
| Other Study ID Numbers: | 08-08-173 R01DA026003 |
| Study First Received: | May 21, 2010 |
| Last Updated: | September 16, 2015 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Friends Research Institute, Inc.:
|
SBIRT Drug abuse |
Additional relevant MeSH terms:
|
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |
ClinicalTrials.gov processed this record on September 26, 2016